{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:10:48Z","timestamp":1793909448369,"version":"4.8.0"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-quality development project of public hospitals in Baoan District, Shenzhen","award":["YNXM2024062"],"award-info":[{"award-number":["YNXM2024062"]}]},{"name":"High-quality development project of public hospitals in Baoan District, Shenzhen","award":["YNXM2024015"],"award-info":[{"award-number":["YNXM2024015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01914-9","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T22:36:41Z","timestamp":1735598201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Decoding TDP-43: the molecular chameleon of neurodegenerative diseases"],"prefix":"10.1186","volume":"12","author":[{"given":"Jixiang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"publisher","first-page":"111106","DOI":"10.1016\/j.celrep.2022.111106","volume":"40","author":"L Duan","year":"2022","unstructured":"Duan L, Zaepfel BL, Aksenova V, Dasso M, Rothstein JD, Kalab P et al (2022) Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export. Cell Rep 40:111106","journal-title":"Cell Rep"},{"key":"1914_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnmol.2019.00301","volume":"12","author":"L Fran\u00e7ois-Moutal","year":"2019","unstructured":"Fran\u00e7ois-Moutal L, Perez-Miller S, Scott DD, Miranda VG, Mollasalehi N, Khanna M (2019) Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front Mol Neurosci 12:301","journal-title":"Front Mol Neurosci"},{"key":"1914_CR3","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.14336\/AD.2023.1118","volume":"15","author":"J Song","year":"2024","unstructured":"Song J (2024) Molecular Mechanisms of Phase Separation and Amyloidosis of ALS\/FTD-linked FUS and TDP-43. Aging Dis 15:2084\u20132112","journal-title":"Aging Dis"},{"key":"1914_CR4","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.pneurobio.2022.102229","volume":"211","author":"SS Keating","year":"2022","unstructured":"Keating SS, San Gil R, Swanson MEV, Scotter EL, Walker AK (2022) TDP-43 pathology: From noxious assembly to therapeutic removal. Prog Neurobiol 211:102229","journal-title":"Prog Neurobiol"},{"key":"1914_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2020","unstructured":"de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T et al (2020) TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92:86\u201395","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1914_CR6","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","volume":"69","author":"SH Ou","year":"1995","unstructured":"Ou SH, Wu F, Harrich D, Garc\u00eda-Mart\u00ednez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69:3584\u20133596","journal-title":"J Virol"},{"key":"1914_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133","journal-title":"Science"},{"key":"1914_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IRA Mackenzie","year":"2007","unstructured":"Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434","journal-title":"Ann Neurol"},{"key":"1914_CR9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668\u20131672","journal-title":"Science"},{"key":"1914_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms10010232","volume":"10","author":"M Neumann","year":"2009","unstructured":"Neumann M (2009) Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 10:232\u2013246","journal-title":"Int J Mol Sci"},{"key":"1914_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256","journal-title":"Neuron"},{"key":"1914_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/2051-5960-1-49","volume":"1","author":"R Liu","year":"2013","unstructured":"Liu R, Yang G, Nonaka T, Arai T, Jia W, Cynader MS (2013) Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta Neuropathol Commun 1:49","journal-title":"Acta Neuropathol Commun"},{"key":"1914_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12929-023-00921-7","volume":"30","author":"Y-L Tseng","year":"2023","unstructured":"Tseng Y-L, Lu P-C, Lee C-C, He R-Y, Huang Y-A, Tseng Y-C et al (2023) Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera. J Biomed Sci 30:27","journal-title":"J Biomed Sci"},{"key":"1914_CR14","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1039\/D1CB00110H","volume":"2","author":"L Francois-Moutal","year":"2021","unstructured":"Francois-Moutal L, Scott DD, Khanna M (2021) Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape. RSC Chem Biol 2:1158\u20131166","journal-title":"RSC Chem Biol"},{"key":"1914_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ydbio.2006.04.443","volume":"295","author":"KK Acharya","year":"2006","unstructured":"Acharya KK, Govind CK, Shore AN, Stoler MH, Reddi PP (2006) cis-requirement for the maintenance of round spermatid-specific transcription. Dev Biol 295:781\u2013790","journal-title":"Dev Biol"},{"key":"1914_CR16","doi-asserted-by":"publisher","first-page":"e1009260","DOI":"10.1371\/journal.pgen.1009260","volume":"16","author":"M Giannini","year":"2020","unstructured":"Giannini M, Bayona-Feliu A, Sproviero D, Barroso SI, Cereda C, Aguilera A (2020) TDP-43 mutations link Amyotrophic Lateral Sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genet 16:e1009260","journal-title":"PLoS Genet"},{"key":"1914_CR17","doi-asserted-by":"crossref","unstructured":"Wood M, Quinet A, Lin Y-L, Davis AA, Pasero P, Ayala YM et al (2020) TDP-43 dysfunction results in R-loop accumulation and DNA replication defects. J Cell Sci 133","DOI":"10.1242\/jcs.244129"},{"key":"1914_CR18","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1073\/pnas.1818415116","volume":"116","author":"J Mitra","year":"2019","unstructured":"Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V et al (2019) Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A 116:4696\u20134705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmb.2011.11.003","volume":"415","author":"M Passoni","year":"2012","unstructured":"Passoni M, De Conti L, Baralle M, Buratti E (2012) UG repeats\/TDP-43 interactions near 5\u2019 splice sites exert unpredictable effects on splicing modulation. J Mol Biol 415:46\u201360","journal-title":"J Mol Biol"},{"key":"1914_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/nar\/gkp1086","volume":"38","author":"N Dreumont","year":"2010","unstructured":"Dreumont N, Hardy S, Behm-Ansmant I, Kister L, Branlant C, St\u00e9venin J et al (2010) Antagonistic factors control the unproductive splicing of SC35 terminal intron. Nucleic Acids Res 38:1353\u20131366","journal-title":"Nucleic Acids Res"},{"key":"1914_CR21","doi-asserted-by":"publisher","first-page":"28852","DOI":"10.1074\/jbc.M805376200","volume":"283","author":"JK Bose","year":"2008","unstructured":"Bose JK, Wang I-F, Hung L, Tarn W-Y, Shen C-KJ (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem 283:28852\u201328859","journal-title":"J Biol Chem"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"194413","DOI":"10.1016\/j.bbagrm.2019.194413","volume":"1862","author":"V Gumina","year":"2019","unstructured":"Gumina V, Colombrita C, Fallini C, Bossolasco P, Maraschi AM, Landers JE et al (2019) TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. Biochim Biophys acta Gene Regul Mech 1862:194413","journal-title":"Biochim Biophys acta Gene Regul Mech"},{"key":"1914_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/brain\/awy062","volume":"141","author":"J-E Deshaies","year":"2018","unstructured":"Deshaies J-E, Shkreta L, Moszczynski AJ, Sidib\u00e9 H, Semmler S, Fouillen A et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141:1320\u20131333","journal-title":"Brain"},{"key":"1914_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41419-022-04867-w","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Ke H, Zhang H, Zou L, Yang Q, Lu X et al (2022) TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms. Cell Death Dis 13:428","journal-title":"Cell Death Dis"},{"key":"1914_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00401-016-1603-8","volume":"132","author":"P Majumder","year":"2016","unstructured":"Majumder P, Chu J-F, Chatterjee B, Swamy KBS, Shen C-KJ (2016) Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP. Acta Neuropathol 132:721\u2013738","journal-title":"Acta Neuropathol"},{"key":"1914_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1074\/jbc.M110.190884","volume":"286","author":"CF Sephton","year":"2011","unstructured":"Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y et al (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 286:1204\u20131215","journal-title":"J Biol Chem"},{"key":"1914_CR27","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1093\/nar\/gkx175","volume":"45","author":"J Gu","year":"2017","unstructured":"Gu J, Wu F, Xu W, Shi J, Hu W, Jin N et al (2017) TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res 45:6177\u20136193","journal-title":"Nucleic Acids Res"},{"key":"1914_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala YM, De Conti L, Avenda\u00f1o-V\u00e1zquez SE, Dhir A, Romano M, D\u2019Ambrogio A et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30:277\u2013288","journal-title":"EMBO J"},{"key":"1914_CR29","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1038\/s41467-018-05049-z","volume":"9","author":"EM Tank","year":"2018","unstructured":"Tank EM, Figueroa-Romero C, Hinder LM, Bedi K, Archbold HC, Li X et al (2018) Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun 9:2845","journal-title":"Nat Commun"},{"key":"1914_CR30","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/emboj.2012.292","volume":"31","author":"X Liu","year":"2012","unstructured":"Liu X, Li D, Zhang W, Guo M, Zhan Q (2012) Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 31:4415\u20134427","journal-title":"EMBO J"},{"key":"1914_CR31","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1073\/pnas.0800546105","volume":"105","author":"YM Ayala","year":"2008","unstructured":"Ayala YM, Misteli T, Baralle FE (2008) TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A 105:3785\u20133789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR32","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/brain\/awab217","volume":"144","author":"H Sidib\u00e9","year":"2021","unstructured":"Sidib\u00e9 H, Khalfallah Y, Xiao S, G\u00f3mez NB, Fakim H, Tank EMH et al (2021) TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis\/frontotemporal dementia. Brain 144:3461\u20133476","journal-title":"Brain"},{"key":"1914_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1080\/15476286.2014.996081","volume":"11","author":"L Costessi","year":"2014","unstructured":"Costessi L, Porro F, Iaconcig A, Muro AF (2014) TDP-43 regulates \u03b2-adducin (Add2) transcript stability. RNA Biol 11:1280\u20131290","journal-title":"RNA Biol"},{"key":"1914_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/15548627.2016.1151596","volume":"12","author":"Z Ying","year":"2016","unstructured":"Ying Z, Xia Q, Hao Z, Xu D, Wang M, Wang H et al (2016) TARDBP\/TDP-43 regulates autophagy in both MTORC1-dependent and MTORC1-independent manners. Autophagy 12:707\u2013708","journal-title":"Autophagy"},{"key":"1914_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41467-019-14183-1","volume":"11","author":"L Zhao","year":"2020","unstructured":"Zhao L, Ke H, Xu H, Wang G-D, Zhang H, Zou L et al (2020) TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh. Nat Commun 11:341","journal-title":"Nat Commun"},{"key":"1914_CR36","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41598-017-06953-y","volume":"7","author":"K Izumikawa","year":"2017","unstructured":"Izumikawa K, Nobe Y, Yoshikawa H, Ishikawa H, Miura Y, Nakayama H et al (2017) TDP-43 stabilises the processing intermediates of mitochondrial transcripts. Sci Rep 7:7709","journal-title":"Sci Rep"},{"key":"1914_CR37","doi-asserted-by":"publisher","first-page":"10600","DOI":"10.1074\/jbc.M117.783498","volume":"292","author":"J Gu","year":"2017","unstructured":"Gu J, Chen F, Iqbal K, Gong C-X, Wang X, Liu F (2017) Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies. J Biol Chem 292:10600\u201310612","journal-title":"J Biol Chem"},{"key":"1914_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neurobiolaging.2015.09.022","volume":"37","author":"M Niblock","year":"2016","unstructured":"Niblock M, Hortob\u00e1gyi T, Troakes C, Al-Sarraj S, Spickett C, Jones R et al (2016) Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer\u2019s disease. Neurobiol Aging 37:45\u201346","journal-title":"Neurobiol Aging"},{"key":"1914_CR39","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1038\/s41598-018-25767-0","volume":"8","author":"Y Khalfallah","year":"2018","unstructured":"Khalfallah Y, Kuta R, Grasmuck C, Prat A, Durham HD, Vande Velde C (2018) TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci Rep 8:7551","journal-title":"Sci Rep"},{"key":"1914_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ng.2853","volume":"46","author":"H-J Kim","year":"2014","unstructured":"Kim H-J, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ et al (2014) Therapeutic modulation of eIF2\u03b1 phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet 46:152\u2013160","journal-title":"Nat Genet"},{"key":"1914_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2012.02.032","volume":"1462","author":"CM Dewey","year":"2012","unstructured":"Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G (2012) TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res 1462:16\u201325","journal-title":"Brain Res"},{"key":"1914_CR42","doi-asserted-by":"publisher","first-page":"104639","DOI":"10.1016\/j.nbd.2019.104639","volume":"134","author":"Y Baradaran-Heravi","year":"2020","unstructured":"Baradaran-Heravi Y, Van Broeckhoven C, van der Zee J (2020) Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol Dis 134:104639","journal-title":"Neurobiol Dis"},{"key":"1914_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J et al (2016) The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med 22:869\u2013878","journal-title":"Nat Med"},{"key":"1914_CR44","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1093\/nar\/gkt1407","volume":"42","author":"P-H Kuo","year":"2014","unstructured":"Kuo P-H, Chiang C-H, Wang Y-T, Doudeva LG, Yuan HS (2014) The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Res 42:4712\u20134722","journal-title":"Nucleic Acids Res"},{"key":"1914_CR45","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1177\/1087057110382778","volume":"15","author":"JA Cassel","year":"2010","unstructured":"Cassel JA, Blass BE, Reitz AB, Pawlyk AC (2010) Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using AlphaScreen technology. J Biomol Screen 15:1099\u20131106","journal-title":"J Biomol Screen"},{"key":"1914_CR46","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/nar\/gkp013","volume":"37","author":"P-H Kuo","year":"2009","unstructured":"Kuo P-H, Doudeva LG, Wang Y-T, Shen C-KJ, Yuan HS (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 37:1799\u20131808","journal-title":"Nucleic Acids Res"},{"key":"1914_CR47","doi-asserted-by":"publisher","first-page":"18619","DOI":"10.1073\/pnas.1413994112","volume":"111","author":"H Qin","year":"2014","unstructured":"Qin H, Lim L-Z, Wei Y, Song J (2014) TDP-43\u00a0N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA. Proc Natl Acad Sci U S A 111:18619\u201318624","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-020-2580-3","volume":"11","author":"S Sanna","year":"2020","unstructured":"Sanna S, Esposito S, Masala A, Sini P, Nieddu G, Galioto M et al (2020) HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death Dis 11:369","journal-title":"Cell Death Dis"},{"key":"1914_CR49","doi-asserted-by":"crossref","unstructured":"Li J, Zhao W, Li Q, Huang Z, Shi G, Li C (2020) Long Non-Coding RNA H19 Promotes Porcine Satellite Cell Differentiation by Interacting with TDP43. Genes (Basel) 11","DOI":"10.3390\/genes11030259"},{"key":"1914_CR50","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41598-020-62375-3","volume":"10","author":"A Rathore","year":"2020","unstructured":"Rathore A, Iketani S, Wang P, Jia M, Sahi V, Ho DD (2020) CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models. Sci Rep 10:5350","journal-title":"Sci Rep"},{"key":"1914_CR51","doi-asserted-by":"crossref","unstructured":"Pandya-Jones A, Markaki Y, Serizay J, Chitiashvili T, Leon WRM, Damianov A et al (2020) Publisher Correction: A protein assembly mediates Xist localization and gene silencing. Nature. England; p. E30","DOI":"10.1101\/2020.03.09.979369"},{"key":"1914_CR52","doi-asserted-by":"publisher","first-page":"eaay2670","DOI":"10.1126\/sciadv.aay2670","volume":"5","author":"S Keihani","year":"2019","unstructured":"Keihani S, Kluever V, Mandad S, Bansal V, Rahman R, Fritsch E et al (2019) The long noncoding RNA neuroLNC regulates presynaptic activity by interacting with the neurodegeneration-associated protein TDP-43. Sci Adv 5:eaay2670","journal-title":"Sci Adv"},{"key":"1914_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/jmcb\/mjy025","volume":"10","author":"G Militello","year":"2018","unstructured":"Militello G, Hosen MR, Ponomareva Y, Gellert P, Weirick T, John D et al (2018) A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1. J Mol Cell Biol 10:102\u2013117","journal-title":"J Mol Cell Biol"},{"key":"1914_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jre.12227","volume":"50","author":"H Murata","year":"2015","unstructured":"Murata H, Hattori T, Maeda H, Takashiba S, Takigawa M, Kido J et al (2015) Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-\u03b1 expression upon lipopolysaccharide stimulation in human monocytes. J Periodontal Res 50:452\u2013460","journal-title":"J Periodontal Res"},{"key":"1914_CR55","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1074\/jbc.M110.166587","volume":"286","author":"AS Lalmansingh","year":"2011","unstructured":"Lalmansingh AS, Urekar CJ, Reddi PP (2011) TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo. J Biol Chem 286:10970\u201310982","journal-title":"J Biol Chem"},{"key":"1914_CR56","doi-asserted-by":"publisher","first-page":"eadf6895","DOI":"10.1126\/sciadv.adf6895","volume":"9","author":"K Oiwa","year":"2023","unstructured":"Oiwa K, Watanabe S, Onodera K, Iguchi Y, Kinoshita Y, Komine O et al (2023) Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis. Sci Adv 9:eadf6895","journal-title":"Sci Adv"},{"key":"1914_CR57","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41582-023-00870-7","volume":"19","author":"H Wood","year":"2023","unstructured":"Wood H (2023) New mechanistic insights into TDP-43 pathology. Nat Rev Neurol 19:574","journal-title":"Nat Rev Neurol"},{"key":"1914_CR58","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41586-023-06405-w","volume":"620","author":"D Arseni","year":"2023","unstructured":"Arseni D, Chen R, Murzin AG, Peak-Chew SY, Garringer HJ, Newell KL et al (2023) TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620:898\u2013903","journal-title":"Nature"},{"key":"1914_CR59","doi-asserted-by":"publisher","first-page":"e1009882","DOI":"10.1371\/journal.pgen.1009882","volume":"17","author":"J Azpurua","year":"2021","unstructured":"Azpurua J, El-Karim EG, Tranquille M, Dubnau J (2021) A behavioral screen for mediators of age-dependent TDP-43 neurodegeneration identifies SF2\/SRSF1 among a group of potent suppressors in both neurons and glia. PLoS Genet 17:e1009882","journal-title":"PLoS Genet"},{"key":"1914_CR60","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1016\/j.cub.2017.10.024","volume":"27","author":"A Berson","year":"2017","unstructured":"Berson A, Sartoris A, Nativio R, Van Deerlin V, Toledo JB, Porta S et al (2017) TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling. Curr Biol 27:3579\u20133590e6","journal-title":"Curr Biol"},{"key":"1914_CR61","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1093\/hmg\/ddx301","volume":"26","author":"M Tibshirani","year":"2017","unstructured":"Tibshirani M, Zhao B, Gentil BJ, Minotti S, Marques C, Keith J et al (2017) Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis. Hum Mol Genet 26:4142\u20134152","journal-title":"Hum Mol Genet"},{"key":"1914_CR62","doi-asserted-by":"publisher","first-page":"e44099","DOI":"10.1371\/journal.pone.0044099","volume":"7","author":"W Li","year":"2012","unstructured":"Li W, Jin Y, Prazak L, Hammell M, Dubnau J (2012) Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS ONE 7:e44099","journal-title":"PLoS ONE"},{"key":"1914_CR63","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB (2019) Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons. Cell Rep 27:1409\u20131421e6","journal-title":"Cell Rep"},{"key":"1914_CR64","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.celrep.2019.09.066","volume":"29","author":"OH Tam","year":"2019","unstructured":"Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S et al (2019) Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep 29:1164\u20131177e5","journal-title":"Cell Rep"},{"key":"1914_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2018.08.009","volume":"390","author":"A Masala","year":"2018","unstructured":"Masala A, Sanna S, Esposito S, Rassu M, Galioto M, Zinellu A et al (2018) Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes. Neuroscience 390:1\u201311","journal-title":"Neuroscience"},{"key":"1914_CR66","doi-asserted-by":"publisher","first-page":"581942","DOI":"10.3389\/fcell.2020.581942","volume":"8","author":"S Lee","year":"2020","unstructured":"Lee S, Kwon Y, Kim S, Jo M, Jeon Y-M, Cheon M et al (2020) The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment. Front cell Dev Biol 8:581942","journal-title":"Front cell Dev Biol"},{"key":"1914_CR67","first-page":"1","volume":"95","author":"LB DE OLIVEIRA REIS AH, Figalo","year":"2023","unstructured":"DE OLIVEIRA REIS AH, Figalo LB, Orsini M, Lemos B (2023) The implications of DNA methylation for amyotrophic lateral sclerosis. Acad Bras Cienc 95:1\u201311","journal-title":"Acad Bras Cienc"},{"key":"1914_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/nan.12625","volume":"47","author":"C Appleby-Mallinder","year":"2021","unstructured":"Appleby-Mallinder C, Schaber E, Kirby J, Shaw PJ, Cooper-Knock J, Heath PR et al (2021) TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 47:61\u201372","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1914_CR69","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1093\/brain\/awad075","volume":"146","author":"A Catanese","year":"2023","unstructured":"Catanese A, Rajkumar S, Sommer D, Masrori P, Hersmus N, Van Damme P et al (2023) Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis. Brain 146:3770\u20133782","journal-title":"Brain"},{"key":"1914_CR70","doi-asserted-by":"publisher","first-page":"624290","DOI":"10.3389\/fgene.2021.624290","volume":"12","author":"O Sharifi","year":"2021","unstructured":"Sharifi O, Yasui DH (2021) The Molecular Functions of MeCP2 in Rett Syndrome Pathology. Front Genet 12:624290","journal-title":"Front Genet"},{"key":"1914_CR71","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1038\/s41467-018-06543-0","volume":"9","author":"C-Y Chung","year":"2018","unstructured":"Chung C-Y, Berson A, Kennerdell JR, Sartoris A, Unger T, Porta S et al (2018) Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity. Nat Commun 9:4406","journal-title":"Nat Commun"},{"key":"1914_CR72","doi-asserted-by":"publisher","first-page":"e0141836","DOI":"10.1371\/journal.pone.0141836","volume":"10","author":"A Amlie-Wolf","year":"2015","unstructured":"Amlie-Wolf A, Ryvkin P, Tong R, Dragomir I, Suh E, Xu Y et al (2015) Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin. PLoS ONE 10:e0141836","journal-title":"PLoS ONE"},{"key":"1914_CR73","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1172\/JCI44867","volume":"121","author":"LM Igaz","year":"2011","unstructured":"Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T et al (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 121:726\u2013738","journal-title":"J Clin Invest"},{"key":"1914_CR74","doi-asserted-by":"publisher","first-page":"105050","DOI":"10.1016\/j.nbd.2020.105050","volume":"144","author":"E Feneberg","year":"2020","unstructured":"Feneberg E, Gordon D, Thompson AG, Finelli MJ, Dafinca R, Candalija A et al (2020) An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol Dis 144:105050","journal-title":"Neurobiol Dis"},{"key":"1914_CR75","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/pr901076y","volume":"9","author":"BD Freibaum","year":"2010","unstructured":"Freibaum BD, Chitta RK, High AA, Taylor JP (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9:1104\u20131120","journal-title":"J Proteome Res"},{"key":"1914_CR76","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1016\/j.cell.2021.07.018","volume":"184","author":"M Hallegger","year":"2021","unstructured":"Hallegger M, Chakrabarti AM, Lee FCY, Lee BL, Amalietti AG, Odeh HM et al (2021) TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell 184:4680\u20134696e22","journal-title":"Cell"},{"key":"1914_CR77","doi-asserted-by":"crossref","unstructured":"Rengifo-Gonzalez JC, El Hage K, Cl\u00e9ment M-J, Steiner E, Joshi V, Craveur P et al (2021) The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation. Elife.;10","DOI":"10.7554\/eLife.67605"},{"key":"1914_CR78","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1073\/pnas.1917038117","volume":"117","author":"JJ Herzog","year":"2020","unstructured":"Herzog JJ, Xu W, Deshpande M, Rahman R, Suib H, Rodal AA et al (2020) TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression. Proc Natl Acad Sci U S A 117:11760\u201311769","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR79","doi-asserted-by":"crossref","unstructured":"Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN et al (2018) A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J.;37","DOI":"10.15252\/embj.201797452"},{"key":"1914_CR80","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen AB, Sahin U (2020) Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J 287:3110\u20133140","journal-title":"FEBS J"},{"key":"1914_CR81","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1007\/s12035-021-02505-8","volume":"58","author":"A Maraschi","year":"2021","unstructured":"Maraschi A, Gumina V, Dragotto J, Colombrita C, Mompe\u00e1n M, Buratti E et al (2021) SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution. Mol Neurobiol 58:5682\u20135702","journal-title":"Mol Neurobiol"},{"key":"1914_CR82","doi-asserted-by":"publisher","first-page":"e51649","DOI":"10.15252\/embr.202051649","volume":"22","author":"M-J Zhao","year":"2021","unstructured":"Zhao M-J, Yao X, Wei P, Zhao C, Cheng M, Zhang D et al (2021) O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43\u2019s mRNA splicing activity. EMBO Rep 22:e51649","journal-title":"EMBO Rep"},{"key":"1914_CR83","doi-asserted-by":"crossref","unstructured":"Necarsulmer JC, Simon JM, Evangelista BA, Chen Y, Tian X, Nafees S et al (2023) RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy. Elife.;12","DOI":"10.7554\/eLife.85921"},{"key":"1914_CR84","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41467-022-28822-7","volume":"13","author":"J Garcia Morato","year":"2022","unstructured":"Garcia Morato J, Hans F, von Zweydorf F, Feederle R, Els\u00e4sser SJ, Skodras AA et al (2022) Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43. Nat Commun 13:1223","journal-title":"Nat Commun"},{"key":"1914_CR85","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-020-0550-4","volume":"13","author":"S Watanabe","year":"2020","unstructured":"Watanabe S, Oiwa K, Murata Y, Komine O, Sobue A, Endo F et al (2020) ALS-linked TDP-43(M337V) knock-in mice exhibit splicing deregulation without neurodegeneration. Mol Brain 13:8","journal-title":"Mol Brain"},{"key":"1914_CR86","doi-asserted-by":"crossref","unstructured":"Narayanan RK, Panwar A, Butler TJ, Cutrupi AN, Kennerson M, Vucic S et al (2023) Transgenic mice overexpressing mutant TDP-43 show aberrant splicing of neurological disorders-associated gene Zmynd11 prior to onset of motor symptoms. microPublication Biol.;2023","DOI":"10.1101\/2022.12.11.519991"},{"key":"1914_CR87","doi-asserted-by":"crossref","unstructured":"Cao MC, Scotter EL (2022) Transcriptional targets of amyotrophic lateral sclerosis\/frontotemporal dementia protein TDP-43 - meta-analysis and interactive graphical database. Dis Model Mech.;15","DOI":"10.1242\/dmm.049418"},{"key":"1914_CR88","doi-asserted-by":"crossref","unstructured":"Zeng Y, Lovchykova A, Akiyama T, Liu C, Guo C, Jawahar VM et al (2024) TDP-43 nuclear loss in FTD\/ALS causes widespread alternative polyadenylation changes. bioRxiv Prepr. Serv. Biol. United States","DOI":"10.1101\/2024.01.22.575730"},{"key":"1914_CR89","doi-asserted-by":"crossref","unstructured":"Arnold FJ, Cui Y, Michels S, Colwin MR, Stockford C, Ye W et al (2024) TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS\/FTD and related disorders. bioRxiv Prepr. Serv. Biol. United States","DOI":"10.1101\/2024.01.22.576709"},{"key":"1914_CR90","doi-asserted-by":"crossref","unstructured":"Bryce-Smith S, Brown A-L, Mehta PR, Mattedi F, Mikheenko A, Barattucci S et al (2024) TDP-43 loss induces extensive cryptic polyadenylation in ALS\/FTD. bioRxiv Prepr. Serv. Biol. United States","DOI":"10.1101\/2024.01.22.576625"},{"key":"1914_CR91","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/brain\/awab078","volume":"144","author":"GE Tyzack","year":"2021","unstructured":"Tyzack GE, Neeves J, Crerar H, Klein P, Ziff O, Taha DM et al (2021) Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis. Brain 144:1985\u20131993","journal-title":"Brain"},{"key":"1914_CR92","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling JP, Pletnikova O, Troncoso JC, Wong PC (2015) TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349:650\u2013655","journal-title":"Science"},{"key":"1914_CR93","doi-asserted-by":"crossref","unstructured":"Koike Y, Pickles S, Ayuso VE, Jansen-West K, Qi YA, Li Z et al (2023) Correction: TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS\/FTD risk gene, UNC13A. PLoS Biol. United States, p e3002228","DOI":"10.1371\/journal.pbio.3002228"},{"key":"1914_CR94","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F et al (2022) TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603:124\u2013130","journal-title":"Nature"},{"key":"1914_CR95","doi-asserted-by":"crossref","unstructured":"Heo D, Ling JP, Molina-Castro GC, Langseth AJ, Waisman A, Nave K-A et al (2022) Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43. Elife.;11","DOI":"10.7554\/eLife.75230"},{"key":"1914_CR96","doi-asserted-by":"crossref","unstructured":"Chang K-J, Agrawal I, Vainshtein A, Ho WY, Xin W, Tucker-Kellogg G et al (2021) TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells. Elife.;10","DOI":"10.7554\/eLife.64456"},{"key":"1914_CR97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA et al (2019) ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci 22:167\u2013179","journal-title":"Nat Neurosci"},{"key":"1914_CR98","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed Z, L\u00f3pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y et al (2019) Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci 22:180\u2013190","journal-title":"Nat Neurosci"},{"key":"1914_CR99","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-020-00987-6","volume":"8","author":"M Briese","year":"2020","unstructured":"Briese M, Saal-Bauernschubert L, L\u00fcningschr\u00f6r P, Moradi M, Dombert B, Surrey V et al (2020) Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol Commun 8:116","journal-title":"Acta Neuropathol Commun"},{"key":"1914_CR100","doi-asserted-by":"crossref","unstructured":"San Juan IG, Nash LA, Smith KS, Leyton-Jaimes MF, Qian M, Klim JR et al (2022) Loss of mouse Stmn2 function causes motor neuropathy. Neuron. United States, p 4031","DOI":"10.1016\/j.neuron.2022.11.003"},{"key":"1914_CR101","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn MW, Melamed Z, L\u00f3pez-Erauskin J, Beccari MS, Ling K, Zuberi A et al (2023) Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379:1140\u20131149","journal-title":"Science"},{"key":"1914_CR102","doi-asserted-by":"publisher","first-page":"eadg7162","DOI":"10.1126\/scitranslmed.adg7162","volume":"16","author":"S Seddighi","year":"2024","unstructured":"Seddighi S, Qi YA, Brown A-L, Wilkins OG, Bereda C, Belair C et al (2024) Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci Transl Med 16:eadg7162","journal-title":"Sci Transl Med"},{"key":"1914_CR103","doi-asserted-by":"crossref","unstructured":"Irwin KE, Jasin P, Braunstein KE, Sinha IR, Garret MA, Bowden KD et al (2024) Author Correction: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. Nat. Med. United States; p. 1504","DOI":"10.1101\/2023.01.23.525202"},{"key":"1914_CR104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00401-023-02655-0","volume":"147","author":"AR Agra Almeida Quadros","year":"2024","unstructured":"Agra Almeida Quadros AR, Li Z, Wang X, Ndayambaje IS, Aryal S, Ramesh N et al (2024) Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer\u2019s disease. Acta Neuropathol 147:9","journal-title":"Acta Neuropathol"},{"key":"1914_CR105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-023-00646-z","volume":"18","author":"V Estades Ayuso","year":"2023","unstructured":"Estades Ayuso V, Pickles S, Todd T, Yue M, Jansen-West K, Song Y et al (2023) TDP-43-regulated cryptic RNAs accumulate in Alzheimer\u2019s disease brains. Mol Neurodegener 18:57","journal-title":"Mol Neurodegener"},{"key":"1914_CR106","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/280339a0","volume":"280","author":"MT Hsu","year":"1979","unstructured":"Hsu MT, Coca-Prados M (1979) Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 280:339\u2013340","journal-title":"Nature"},{"key":"1914_CR107","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnmol.2016.00074","volume":"9","author":"D van Rossum","year":"2016","unstructured":"van Rossum D, Verheijen BM, Pasterkamp RJ (2016) Circular RNAs: Novel Regulators of Neuronal Development. Front Mol Neurosci 9:74","journal-title":"Front Mol Neurosci"},{"key":"1914_CR108","doi-asserted-by":"crossref","unstructured":"Xiao Y, Qiu M, Tan C, Huang W, Hu S, Jiang X et al (2022) Systematic analysis of circRNA biomarkers for diagnosis, prognosis and therapy in colorectal cancer. Front. Genet. Switzerland; p. 938672","DOI":"10.3389\/fgene.2022.938672"},{"key":"1914_CR109","doi-asserted-by":"crossref","unstructured":"Allegra A, Cicero N, Tonacci A, Musolino C, Gangemi S (2022) Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma. Cancers (Basel).;14","DOI":"10.3390\/cancers14071700"},{"key":"1914_CR110","doi-asserted-by":"publisher","first-page":"714958","DOI":"10.3389\/fmed.2021.714958","volume":"8","author":"J Yu","year":"2021","unstructured":"Yu J, Xie D, Huang N, Zhou Q (2021) Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease. Front Med 8:714958","journal-title":"Front Med"},{"key":"1914_CR111","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G (2021) CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis 12:468","journal-title":"Cell Death Dis"},{"key":"1914_CR112","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"W-Y Zhou","year":"2020","unstructured":"Zhou W-Y, Cai Z-R, Liu J, Wang D-S, Ju H-Q, Xu R-H (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19:172","journal-title":"Mol Cancer"},{"key":"1914_CR113","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1101\/gad.270421.115","volume":"29","author":"MC Kramer","year":"2015","unstructured":"Kramer MC, Liang D, Tatomer DC, Gold B, March ZM, Cherry S et al (2015) Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev 29:2168\u20132182","journal-title":"Genes Dev"},{"key":"1914_CR114","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1261\/rna.5290903","volume":"9","author":"H Nielsen","year":"2003","unstructured":"Nielsen H, Fiskaa T, Birgisdottir AB, Haugen P, Einvik C, Johansen S (2003) The ability to form full-length intron RNA circles is a general property of nuclear group I introns. RNA 9:1464\u20131475","journal-title":"RNA"},{"key":"1914_CR115","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-019-0674-x","volume":"7","author":"L-S Wu","year":"2019","unstructured":"Wu L-S, Cheng W-C, Chen C-Y, Wu M-C, Wang Y-C, Tseng Y-H et al (2019) Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons. Acta Neuropathol Commun 7:50","journal-title":"Acta Neuropathol Commun"},{"key":"1914_CR116","doi-asserted-by":"crossref","unstructured":"Ravnik Glava\u010d M, Mezzavilla M, Dolinar A, Koritnik B, Glava\u010d D (2023) Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS. Biomedicines.;11","DOI":"10.3390\/biomedicines11051316"},{"key":"1914_CR117","doi-asserted-by":"publisher","first-page":"8052","DOI":"10.1007\/s12035-019-1627-x","volume":"56","author":"A Dolinar","year":"2019","unstructured":"Dolinar A, Koritnik B, Glava\u010d D, Ravnik-Glava\u010d M (2019) Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis. Mol Neurobiol 56:8052\u20138062","journal-title":"Mol Neurobiol"},{"key":"1914_CR118","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y et al (2019) Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci 76:441\u2013451","journal-title":"Cell Mol Life Sci"},{"key":"1914_CR119","doi-asserted-by":"publisher","first-page":"1374843","DOI":"10.3389\/fmolb.2024.1374843","volume":"11","author":"C Hynes","year":"2024","unstructured":"Hynes C, Kakumani PK (2024) Regulatory role of RNA-binding proteins in microRNA biogenesis. Front Mol Biosci 11:1374843","journal-title":"Front Mol Biosci"},{"key":"1914_CR120","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13148-016-0200-y","volume":"8","author":"S Butkyt\u0117","year":"2016","unstructured":"Butkyt\u0117 S, \u010ciupas L, Jakubauskien\u0117 E, Vilys L, Mocevicius P, Kanopka A et al (2016) Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells. Clin Epigenetics 8:33","journal-title":"Clin Epigenetics"},{"key":"1914_CR121","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cell.2007.06.028","volume":"130","author":"K Okamura","year":"2007","unstructured":"Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC (2007) The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130:89\u2013100","journal-title":"Cell"},{"key":"1914_CR122","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/j.1742-4658.2010.07643.x","volume":"277","author":"E Buratti","year":"2010","unstructured":"Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F (2010) Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J 277:2268\u20132281","journal-title":"FEBS J"},{"key":"1914_CR123","doi-asserted-by":"publisher","first-page":"166695","DOI":"10.1016\/j.jmb.2020.10.029","volume":"432","author":"ZCE Hawley","year":"2020","unstructured":"Hawley ZCE, Campos-Melo D, Strong MJ (2020) Evidence of A Negative Feedback Network Between TDP-43 and miRNAs Dependent on TDP-43 Nuclear Localization. J Mol Biol 432:166695","journal-title":"J Mol Biol"},{"key":"1914_CR124","doi-asserted-by":"crossref","unstructured":"Ruffo P, Catalano S, La Bella V, Conforti FL (2023) Deregulation of Plasma microRNA Expression in a TARDBP-ALS Family. Biomolecules.;13","DOI":"10.3390\/biom13040706"},{"key":"1914_CR125","doi-asserted-by":"crossref","unstructured":"Vassileff N, Spiers JG, Lee JD, Woodruff TM, Ebrahimie E, Mohammadi Dehcheshmeh M et al (2024) A Panel of miRNA Biomarkers Common to Serum and Brain-Derived Extracellular Vesicles Identified in Mouse Model of Amyotrophic Lateral Sclerosis. Mol Neurobiol","DOI":"10.1007\/s12035-023-03857-z"},{"key":"1914_CR126","doi-asserted-by":"crossref","unstructured":"Nilaver BI, Urbanski HF (2023) Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review. Front Aging Neurosci.;15","DOI":"10.3389\/fnagi.2023.1142617"},{"key":"1914_CR127","first-page":"132","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao J, Wang L, Huntley ML, Perry G, Wang X (2018) Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem 8:132\u2013156","journal-title":"J Neurochem"},{"key":"1914_CR128","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fncel.2017.00243","volume":"11","author":"AN Coyne","year":"2017","unstructured":"Coyne AN, Zaepfel BL, Zarnescu DC (2017) Failure to Deliver and Translate-New Insights into RNA Dysregulation in ALS. Front Cell Neurosci 11:243","journal-title":"Front Cell Neurosci"},{"key":"1914_CR129","doi-asserted-by":"crossref","unstructured":"Pham J, Keon M, Brennan S, Saksena N (2020) Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy. Int J Mol Sci.;21","DOI":"10.3390\/ijms21103464"},{"key":"1914_CR130","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fncel.2016.00204","volume":"10","author":"JA Clark","year":"2016","unstructured":"Clark JA, Yeaman EJ, Blizzard CA, Chuckowree JA, Dickson TC (2016) A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease. Front Cell Neurosci 10:204","journal-title":"Front Cell Neurosci"},{"key":"1914_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-020-00386-4","volume":"15","author":"A Konopka","year":"2020","unstructured":"Konopka A, Whelan DR, Jamali MS, Perri E, Shahheydari H, Toth RP et al (2020) Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol Neurodegener 15:51","journal-title":"Mol Neurodegener"},{"key":"1914_CR132","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.nbd.2020.104939","volume":"141","author":"SA Koren","year":"2020","unstructured":"Koren SA, Galvis-Escobar S, Abisambra JF (2020) Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies. Neurobiol Dis 141:104939","journal-title":"Neurobiol Dis"},{"key":"1914_CR133","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.tibs.2020.12.005","volume":"46","author":"B Portz","year":"2021","unstructured":"Portz B, Lee BL, Shorter J (2021) FUS and TDP-43 Phases in Health and Disease. Trends Biochem Sci 46:550\u2013563","journal-title":"Trends Biochem Sci"},{"key":"1914_CR134","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P et al (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544:367\u2013371","journal-title":"Nature"},{"key":"1914_CR135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.conb.2019.11.018","volume":"61","author":"T Nonaka","year":"2020","unstructured":"Nonaka T, Hasegawa M (2020) Prion-like properties of assembled TDP-43. Curr Opin Neurobiol 61:23\u201328","journal-title":"Curr Opin Neurobiol"},{"key":"1914_CR136","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/brain\/awz419","volume":"143","author":"P Smethurst","year":"2020","unstructured":"Smethurst P, Risse E, Tyzack GE, Mitchell JS, Taha DM, Chen Y-R et al (2020) Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain 143:430\u2013440","journal-title":"Brain"},{"key":"1914_CR137","doi-asserted-by":"crossref","unstructured":"Nay K, Smiles WJ, Kaiser J, McAloon LM, Loh K, Galic S et al (2021) Molecular Mechanisms Underlying the Beneficial Effects of Exercise on Brain Function and Neurological Disorders. Int J Mol Sci.;22","DOI":"10.3390\/ijms22084052"},{"key":"1914_CR138","doi-asserted-by":"crossref","unstructured":"Liu G, Byrd A, Warner AN, Pei F, Basha E, Buchanan A et al (2020) Cdc48\/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover. Mol Cell Biol.;40","DOI":"10.1128\/MCB.00256-19"},{"key":"1914_CR139","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13062-017-0174-5","volume":"12","author":"MS Herrera-Cruz","year":"2017","unstructured":"Herrera-Cruz MS, Simmen T (2017) Of yeast, mice and men: MAMs come in two flavors. Biol Direct 12:3","journal-title":"Biol Direct"},{"key":"1914_CR140","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-020-00219-w","volume":"9","author":"C Huang","year":"2020","unstructured":"Huang C, Yan S, Zhang Z (2020) Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases. Transl Neurodegener 9:40","journal-title":"Transl Neurodegener"},{"key":"1914_CR141","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45","journal-title":"Mol Neurodegener"},{"key":"1914_CR142","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12551-023-01057-6","volume":"15","author":"TA Banarase","year":"2023","unstructured":"Banarase TA, Sammeta SS, Wankhede NL, Mangrulkar SV, Rahangdale SR, Aglawe MM et al (2023) Mitophagy regulation in aging and neurodegenerative disease. Biophys Rev 15:239\u2013255","journal-title":"Biophys Rev"},{"key":"1914_CR143","doi-asserted-by":"publisher","first-page":"tfae008","DOI":"10.1093\/toxres\/tfae008","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu Z, Qiang Y, Shan S, Wang S, Liu Z, Yang Y et al (2024) Aberrant mitochondrial aggregation of TDP-43 activated mitochondrial unfolded protein response and contributed to recovery of acetaminophen induced acute liver injury. Toxicol Res (Camb) 13:tfae008","journal-title":"Toxicol Res (Camb)"},{"key":"1914_CR144","doi-asserted-by":"publisher","first-page":"263310552095730","DOI":"10.1177\/2633105520957302","volume":"15","author":"M-L Floare","year":"2020","unstructured":"Floare M-L, Allen SP (2020) Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neurosci insights 15:2633105520957302","journal-title":"Neurosci insights"},{"key":"1914_CR145","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2017.00063","volume":"11","author":"L Song","year":"2017","unstructured":"Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies. Front Cell Neurosci 11:63","journal-title":"Front Cell Neurosci"},{"key":"1914_CR146","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2019.00063","volume":"13","author":"CM Henstridge","year":"2019","unstructured":"Henstridge CM, Tzioras M, Paolicelli RC (2019) Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration. Front Cell Neurosci 13:63","journal-title":"Front Cell Neurosci"},{"key":"1914_CR147","doi-asserted-by":"crossref","unstructured":"Layalle S, They L, Ourghani S, Raoul C, Soustelle L (2021) Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster. Int J Mol Sci.;22","DOI":"10.3390\/ijms22020904"},{"key":"1914_CR148","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcdb.2019.05.024","volume":"99","author":"L Strohm","year":"2020","unstructured":"Strohm L, Behrends C (2020) Glia-specific autophagy dysfunction in ALS. Semin Cell Dev Biol 99:172\u2013182","journal-title":"Semin Cell Dev Biol"},{"key":"1914_CR149","doi-asserted-by":"crossref","unstructured":"Carillo MR, Bertapelle C, Scial\u00f2 F, Siervo M, Spagnuolo G, Simeone M et al (2020) L-Carnitine in Drosophila: A Review. Antioxidants (Basel, Switzerland).;9","DOI":"10.3390\/antiox9121310"},{"key":"1914_CR150","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1038\/s41598-020-62864-5","volume":"10","author":"J Velebit","year":"2020","unstructured":"Velebit J, Horvat A, Smoli\u010d T, Prpar Mihevc S, Rogelj B, Zorec R et al (2020) Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca(2+) signaling and dysregulated cell metabolism. Sci Rep 10:6003","journal-title":"Sci Rep"},{"key":"1914_CR151","doi-asserted-by":"publisher","first-page":"173737","DOI":"10.1016\/j.ejphar.2020.173737","volume":"892","author":"Y Nakagawa","year":"2021","unstructured":"Nakagawa Y, Yamada S (2021) A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications. Eur J Pharmacol 892:173737","journal-title":"Eur J Pharmacol"},{"key":"1914_CR152","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/07391102.2020.1714481","volume":"39","author":"A Prakash","year":"2021","unstructured":"Prakash A, Kumar V, Banerjee A, Lynn AM, Prasad R (2021) Structural heterogeneity in RNA recognition motif 2 (RRM2) of TAR DNA-binding protein 43 (TDP-43): clue to amyotrophic lateral sclerosis. J Biomol Struct Dyn 39:357\u2013367","journal-title":"J Biomol Struct Dyn"},{"key":"1914_CR153","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2020.01.122","volume":"524","author":"M Dang","year":"2020","unstructured":"Dang M, Song J (2020) ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain. Biochem Biophys Res Commun 524:459\u2013464","journal-title":"Biochem Biophys Res Commun"},{"key":"1914_CR154","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt MF, Gan ZY, Komander D, Dewson G (2021) Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ 28:570\u2013590","journal-title":"Cell Death Differ"},{"key":"1914_CR155","doi-asserted-by":"publisher","first-page":"1142617","DOI":"10.3389\/fnagi.2023.1142617","volume":"15","author":"BI Nilaver","year":"2023","unstructured":"Nilaver BI, Urbanski HF (2023) Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review. Front Aging Neurosci 15:1142617","journal-title":"Front Aging Neurosci"},{"key":"1914_CR156","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng.1085","volume":"44","author":"S Postel-Vinay","year":"2012","unstructured":"Postel-Vinay S, V\u00e9ron AS, Tirode F, Pierron G, Reynaud S, Kovar H et al (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44:323\u2013327","journal-title":"Nat Genet"},{"key":"1914_CR157","doi-asserted-by":"publisher","first-page":"755096","DOI":"10.3389\/fonc.2021.755096","volume":"11","author":"X Ma","year":"2021","unstructured":"Ma X, Ying Y, Xie H, Liu X, Wang X, Li J (2021) The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer. Front Oncol 11:755096","journal-title":"Front Oncol"},{"key":"1914_CR158","first-page":"3285","volume":"10","author":"F Guo","year":"2020","unstructured":"Guo F, Wang H, Jiang M, Yang Q, Xiang Q, Zhou H et al (2020) TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt\/\u03b2-catenin signaling pathway. Am J Cancer Res 10:3285\u20133301","journal-title":"Am J Cancer Res"},{"key":"1914_CR159","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.phymed.2010.11.012","volume":"18","author":"HY Fang","year":"2011","unstructured":"Fang HY, Chen SB, Guo DJ, Pan SY, Yu ZL (2011) Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells. Phytomedicine 18:697\u2013703","journal-title":"Phytomedicine"},{"key":"1914_CR160","doi-asserted-by":"publisher","first-page":"E3426","DOI":"10.1073\/pnas.1714573115","volume":"115","author":"H Ke","year":"2018","unstructured":"Ke H, Zhao L, Zhang H, Feng X, Xu H, Hao J et al (2018) Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3. Proc Natl Acad Sci U S A 115:E3426\u2013E3435","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR161","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbrc.2015.08.027","volume":"465","author":"F Guo","year":"2015","unstructured":"Guo F, Jiao F, Song Z, Li S, Liu B, Yang H et al (2015) Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro. Biochem Biophys Res Commun 465:293\u2013298","journal-title":"Biochem Biophys Res Commun"},{"key":"1914_CR162","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1164\/rccm.201602-0300OC","volume":"195","author":"I-S Chang","year":"2017","unstructured":"Chang I-S, Jiang SS, Yang JC-H, Su W-C, Chien L-H, Hsiao C-F et al (2017) Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors. Am J Respir Crit Care Med 195:663\u2013673","journal-title":"Am J Respir Crit Care Med"},{"key":"1914_CR163","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-021-00847-2","volume":"7","author":"Y Li","year":"2022","unstructured":"Li Y, Shen Y, Xie M, Wang B, Wang T, Zeng J et al (2022) LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1. Signal Transduct Target Ther 7:30","journal-title":"Signal Transduct Target Ther"},{"key":"1914_CR164","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/15384047.2016.1250984","volume":"18","author":"Q Zeng","year":"2017","unstructured":"Zeng Q, Cao K, Liu R, Huang J, Xia K, Tang J et al (2017) Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis. Cancer Biol Ther 18:8\u201315","journal-title":"Cancer Biol Ther"},{"key":"1914_CR165","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/15384101.2018.1542898","volume":"17","author":"S Zaman","year":"2018","unstructured":"Zaman S, Chobrutskiy BI, Blanck G (2018) MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma. Cell Cycle 17:2474\u20132483","journal-title":"Cell Cycle"},{"key":"1914_CR166","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s42003-022-03788-w","volume":"5","author":"B-W Liu","year":"2022","unstructured":"Liu B-W, Wang X-Y, Cao J-L, Chen L-L, Wang Y-L, Zhao B-Q et al (2022) TDP-43 upregulates lipid metabolism modulator ABHD2 to suppress apoptosis in hepatocellular carcinoma. Commun Biol 5:816","journal-title":"Commun Biol"},{"key":"1914_CR167","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.canlet.2016.02.021","volume":"374","author":"PY Kim","year":"2016","unstructured":"Kim PY, Tan O, Liu B, Trahair T, Liu T, Haber M et al (2016) High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Lett 374:315\u2013323","journal-title":"Cancer Lett"},{"key":"1914_CR168","doi-asserted-by":"publisher","first-page":"56612","DOI":"10.18632\/oncotarget.17979","volume":"8","author":"T-W Lin","year":"2017","unstructured":"Lin T-W, Chen M-T, Lin L-T, Huang P-I, Lo W-L, Yang Y-P et al (2017) TDP-43\/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma. Oncotarget 8:56612\u201356625","journal-title":"Oncotarget"},{"key":"1914_CR169","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neulet.2011.11.021","volume":"506","author":"K Lee","year":"2012","unstructured":"Lee K, Suzuki H, Aiso S, Matsuoka M (2012) Overexpression of TDP-43 causes partially p53-dependent G2\/M arrest and p53-independent cell death in HeLa cells. Neurosci Lett 506:271\u2013276","journal-title":"Neurosci Lett"},{"key":"1914_CR170","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s13238-017-0480-9","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Fan Z, McGee W, Chen M, Kong R, Wen P et al (2018) TDP-43 regulates cancer-associated microRNAs. Protein Cell 9:848\u2013866","journal-title":"Protein Cell"},{"key":"1914_CR171","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/neup.12644","volume":"40","author":"Y Riku","year":"2020","unstructured":"Riku Y (2020) Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology 40:426\u2013435","journal-title":"Neuropathology"},{"key":"1914_CR172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-023-00665-w","volume":"18","author":"M Xie","year":"2023","unstructured":"Xie M, Pallegar PN, Parusel S, Nguyen AT, Wu L-J (2023) Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms. Mol Neurodegener 18:75","journal-title":"Mol Neurodegener"},{"key":"1914_CR173","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40035-015-0036-y","volume":"4","author":"S Yamashita","year":"2015","unstructured":"Yamashita S, Ando Y (2015) Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener 4:13","journal-title":"Transl Neurodegener"},{"key":"1914_CR174","doi-asserted-by":"crossref","unstructured":"Cihankaya H, Theiss C, Matschke V (2021) Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis. Int J Mol Sci.;22","DOI":"10.3390\/ijms22030993"},{"key":"1914_CR175","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortob\u00e1gyi T, De Vos KJ, Nishimura AL, Sreedharan J et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208\u20131211","journal-title":"Science"},{"key":"1914_CR176","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-011-0932-x","volume":"123","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L et al (2012) Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol 123:395\u2013407","journal-title":"Acta Neuropathol"},{"key":"1914_CR177","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-014-1299-6","volume":"128","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider J, Arai K, Del Tredici K, Toledo JB, Robinson JL, Lee EB et al (2014) TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 128:423\u2013437","journal-title":"Acta Neuropathol"},{"key":"1914_CR178","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20\u201338","journal-title":"Ann Neurol"},{"key":"1914_CR179","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2020.03.019","volume":"92","author":"P Wong","year":"2020","unstructured":"Wong P, Ho WY, Yen Y-C, Sanford E, Ling S-C (2020) The vulnerability of motor and frontal cortex-dependent behaviors in mice expressing ALS-linked mutation in TDP-43. Neurobiol Aging 92:43\u201360","journal-title":"Neurobiol Aging"},{"key":"1914_CR180","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jnc.15214","volume":"157","author":"MS Dyer","year":"2021","unstructured":"Dyer MS, Reale LA, Lewis KE, Walker AK, Dickson TC, Woodhouse A et al (2021) Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex. J Neurochem 157:1300\u20131315","journal-title":"J Neurochem"},{"key":"1914_CR181","doi-asserted-by":"publisher","first-page":"1253543","DOI":"10.3389\/fncel.2023.1253543","volume":"17","author":"A Pisciottani","year":"2023","unstructured":"Pisciottani A, Croci L, Lauria F, Marullo C, Savino E, Ambrosi A et al (2023) Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis. Front Cell Neurosci 17:1253543","journal-title":"Front Cell Neurosci"},{"key":"1914_CR182","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-023-00623-6","volume":"18","author":"A Ionescu","year":"2023","unstructured":"Ionescu A, Altman T, Perlson E (2023) Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS. Mol Neurodegener 18:35","journal-title":"Mol Neurodegener"},{"key":"1914_CR183","doi-asserted-by":"publisher","first-page":"E1111","DOI":"10.1073\/pnas.1620293114","volume":"114","author":"KY Shi","year":"2017","unstructured":"Shi KY, Mori E, Nizami ZF, Lin Y, Kato M, Xiang S et al (2017) Toxic PR(n) poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc Natl Acad Sci U S A 114:E1111\u2013E1117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1914_CR184","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainres.2018.01.015","volume":"1693","author":"K Weskamp","year":"2018","unstructured":"Weskamp K, Barmada SJ (2018) TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res 1693:67\u201374","journal-title":"Brain Res"},{"key":"1914_CR185","doi-asserted-by":"publisher","first-page":"1300705","DOI":"10.3389\/fnins.2023.1300705","volume":"17","author":"RJ Eck","year":"2023","unstructured":"Eck RJ, Stair JG, Kraemer BC, Liachko NF (2023) Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Front Neurosci 17:1300705","journal-title":"Front Neurosci"},{"key":"1914_CR186","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s12035-022-02847-x","volume":"59","author":"Y-Z Liao","year":"2022","unstructured":"Liao Y-Z, Ma J, Dou J-Z (2022) The Role of TDP-43 in Neurodegenerative Disease. Mol Neurobiol 59:4223\u20134241","journal-title":"Mol Neurobiol"},{"key":"1914_CR187","doi-asserted-by":"publisher","first-page":"102441","DOI":"10.1016\/j.arr.2024.102441","volume":"100","author":"P-C Ho","year":"2024","unstructured":"Ho P-C, Hsieh T-C, Tsai K-J (2024) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies. Ageing Res Rev 100:102441","journal-title":"Ageing Res Rev"},{"key":"1914_CR188","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","volume":"127","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB et al (2014) Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 127:423\u2013439","journal-title":"Acta Neuropathol"},{"key":"1914_CR189","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-020-00600-x","volume":"12","author":"M Bocchetta","year":"2020","unstructured":"Bocchetta M, Iglesias Espinosa MDM, Lashley T, Warren JD, Rohrer JD (2020) In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology. Alzheimers Res Ther 12:34","journal-title":"Alzheimers Res Ther"},{"key":"1914_CR190","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1212\/WNL.0b013e318202038c","volume":"75","author":"JD Rohrer","year":"2010","unstructured":"Rohrer JD, Geser F, Zhou J, Gennatas ED, Sidhu M, Trojanowski JQ et al (2010) TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology 75:2204\u20132211","journal-title":"Neurology"},{"key":"1914_CR191","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/nan.12668","volume":"47","author":"E Van Schoor","year":"2021","unstructured":"Van Schoor E, Koper MJ, Ospitalieri S, Dedeene L, Tom\u00e9 SO, Vandenberghe R et al (2021) Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS\/FTLD cases. Neuropathol Appl Neurobiol 47:328\u2013345","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1914_CR192","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt102","volume":"4","author":"AM Nicholson","year":"2012","unstructured":"Nicholson AM, Gass J, Petrucelli L, Rademakers R (2012) Progranulin axis and recent developments in frontotemporal lobar degeneration. Alzheimers Res Ther 4:4","journal-title":"Alzheimers Res Ther"},{"key":"1914_CR193","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","volume":"8","author":"R Rademakers","year":"2012","unstructured":"Rademakers R, Neumann M, Mackenzie IR (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 8:423\u2013434","journal-title":"Nat Rev Neurol"},{"key":"1914_CR194","doi-asserted-by":"crossref","unstructured":"McGrowder DA, Miller F, Vaz K, Nwokocha C, Wilson-Clarke C, Anderson-Cross M et al (2021) Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease: Current Evidence and Future Perspectives. Brain Sci.;11","DOI":"10.3390\/brainsci11020215"},{"key":"1914_CR195","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/bpa.12775","volume":"30","author":"J Gu","year":"2020","unstructured":"Gu J, Hu W, Tan X, Qu S, Chu D, Gong C-X et al (2020) Elevation of casein kinase 1\u03b5 associated with TDP-43 and tau pathologies in Alzheimer\u2019s disease. Brain Pathol 30:283\u2013297","journal-title":"Brain Pathol"},{"key":"1914_CR196","doi-asserted-by":"publisher","first-page":"757","DOI":"10.24976\/Discov.Med.202335178.71","volume":"35","author":"C Zhang","year":"2023","unstructured":"Zhang C (2023) Etiology of Alzheimer\u2019s Disease. Discov Med 35:757\u2013776","journal-title":"Discov Med"},{"key":"1914_CR197","doi-asserted-by":"publisher","first-page":"165580","DOI":"10.1016\/j.bbadis.2019.165580","volume":"1866","author":"J Gao","year":"2020","unstructured":"Gao J, Wang L, Gao C, Arakawa H, Perry G, Wang X (2020) TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer\u2019s disease. Biochim Biophys acta Mol basis Dis 1866:165580","journal-title":"Biochim Biophys acta Mol basis Dis"},{"key":"1914_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N (2021) TDP-43 Pathology in Alzheimer\u2019s Disease. Mol Neurodegener 16:1\u201315","journal-title":"Mol Neurodegener"},{"key":"1914_CR199","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-014-1358-z","volume":"129","author":"N Aoki","year":"2015","unstructured":"Aoki N, Murray ME, Ogaki K, Fujioka S, Rutherford NJ, Rademakers R et al (2015) Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol 129:53\u201364","journal-title":"Acta Neuropathol"},{"key":"1914_CR200","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/bpa.12505","volume":"28","author":"VD Smith","year":"2018","unstructured":"Smith VD, Bachstetter AD, Ighodaro E, Roberts K, Abner EL, Fardo DW et al (2018) Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol 28:264\u2013273","journal-title":"Brain Pathol"},{"key":"1914_CR201","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3233\/JAD-191040","volume":"73","author":"M Buciuc","year":"2020","unstructured":"Buciuc M, Wennberg AM, Weigand SD, Murray ME, Senjem ML, Spychalla AJ et al (2020) Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer\u2019s Disease Neuropathological Changes. J Alzheimers Dis 73:1511\u20131523","journal-title":"J Alzheimers Dis"},{"key":"1914_CR202","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.neurobiolaging.2014.09.001","volume":"36","author":"L Vanden Broeck","year":"2015","unstructured":"Vanden Broeck L, Kleinberger G, Chapuis J, Gistelinck M, Amouyel P, Van Broeckhoven C et al (2015) Functional complementation in Drosophila to predict the pathogenicity of TARDBP variants: evidence for a loss-of-function mechanism. Neurobiol Aging 36:1121\u20131129","journal-title":"Neurobiol Aging"},{"key":"1914_CR203","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2017.12.038","volume":"666","author":"T Mishima","year":"2018","unstructured":"Mishima T, Deshimaru M, Watanabe T, Kubota K, Kinoshita-Kawada M, Yuasa-Kawada J et al (2018) Behavioral defects in a DCTN1(G71A) transgenic mouse model of Perry syndrome. Neurosci Lett 666:98\u2013103","journal-title":"Neurosci Lett"},{"key":"1914_CR204","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ng.293","volume":"41","author":"MJ Farrer","year":"2009","unstructured":"Farrer MJ, Hulihan MM, Kachergus JM, D\u00e4chsel JC, Stoessl AJ, Grantier LL et al (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41:163\u2013165","journal-title":"Nat Genet"},{"key":"1914_CR205","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","volume":"89","author":"T Mishima","year":"2018","unstructured":"Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N et al (2018) Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry 89:482\u2013487","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1914_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2007.07.014","volume":"14","author":"C Wider","year":"2008","unstructured":"Wider C, Wszolek ZK (2008) Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review. Parkinsonism Relat Disord 14:1\u20137","journal-title":"Parkinsonism Relat Disord"},{"key":"1914_CR207","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima T, Koga S, Lin W-L, Kasanuki K, Castanedes-Casey M, Wszolek ZK et al (2017) Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy. J Neuropathol Exp Neurol 76:676\u2013682","journal-title":"J Neuropathol Exp Neurol"},{"key":"1914_CR208","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","volume":"15","author":"C Wider","year":"2009","unstructured":"Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L et al (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281\u2013286","journal-title":"Parkinsonism Relat Disord"},{"key":"1914_CR209","doi-asserted-by":"crossref","unstructured":"Deshimaru M, Kinoshita-Kawada M, Kubota K, Watanabe T, Tanaka Y, Hirano S et al (2021) DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation. Int J Mol Sci.;22","DOI":"10.3390\/ijms22083985"},{"key":"1914_CR210","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","volume":"22","author":"TB Stoker","year":"2022","unstructured":"Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA (2022) Huntington\u2019s disease: diagnosis and management. Pract Neurol 22:32\u201341","journal-title":"Pract Neurol"},{"key":"1914_CR211","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67:1159\u20131165","journal-title":"J Neuropathol Exp Neurol"},{"key":"1914_CR212","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/mds.22697","volume":"24","author":"GG Kovacs","year":"2009","unstructured":"Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ et al (2009) TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24:1843\u20131847","journal-title":"Mov Disord"},{"key":"1914_CR213","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon Y-M, Kim S, Kwon Y, Kim H-J (2020) The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 52:1652\u20131662","journal-title":"Exp Mol Med"},{"key":"1914_CR214","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","volume":"135","author":"I St-Amour","year":"2018","unstructured":"St-Amour I, Turgeon A, Goupil C, Planel E, H\u00e9bert SS (2018) Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease. Acta Neuropathol 135:249\u2013265","journal-title":"Acta Neuropathol"},{"key":"1914_CR215","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00018-019-03059-8","volume":"76","author":"L Coudert","year":"2019","unstructured":"Coudert L, Nonaka T, Bernard E, Hasegawa M, Schaeffer L, Leblanc P (2019) Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models. Cell Mol Life Sci 76:2615\u20132632","journal-title":"Cell Mol Life Sci"},{"key":"1914_CR216","doi-asserted-by":"crossref","unstructured":"Marte L, Boronat S, Barrios R, Barcons-Simon A, Bolognesi B, Cabrera M et al (2022) Expression of Huntingtin and TDP-43 Derivatives in Fission Yeast Can Cause Both Beneficial and Toxic Effects. Int J Mol Sci.;23","DOI":"10.3390\/ijms23073950"},{"key":"1914_CR217","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/hmg\/dds485","volume":"22","author":"A Tauffenberger","year":"2013","unstructured":"Tauffenberger A, Chitramuthu BP, Bateman A, Bennett HPJ, Parker JA (2013) Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington\u2019s disease models. Hum Mol Genet 22:782\u2013794","journal-title":"Hum Mol Genet"},{"key":"1914_CR218","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fnagi.2019.00376","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen Y, Liu M, Wang Y, Peng G (2019) TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy. Front Aging Neurosci 11:376","journal-title":"Front Aging Neurosci"},{"key":"1914_CR219","doi-asserted-by":"crossref","unstructured":"Cho SH, Choi SM, Kim BC, Song WY, Kim HS, Lee KH (2020) An Autopsy-Proven Case of Limbic-Predominant Age-Related TDP-43 Encephalopathy. Yonsei Med. J. Korea (South), pp 731\u2013735","DOI":"10.3349\/ymj.2020.61.8.731"},{"key":"1914_CR220","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jnen\/nlae032","volume":"83","author":"PT Nelson","year":"2024","unstructured":"Nelson PT, Fardo DW, Wu X, Aung KZ, Cykowski MD, Katsumata Y (2024) Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis. J Neuropathol Exp Neurol 83:396\u2013415","journal-title":"J Neuropathol Exp Neurol"},{"key":"1914_CR221","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1212\/WNL.0000000000003610","volume":"88","author":"S Nag","year":"2017","unstructured":"Nag S, Yu L, Wilson RS, Chen E-Y, Bennett DA, Schneider JA (2017) TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 88:653\u2013660","journal-title":"Neurology"},{"key":"1914_CR222","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00115-020-00922-z","volume":"92","author":"D G\u00f6r\u00df","year":"2021","unstructured":"G\u00f6r\u00df D, Kilimann I, Dyrba M, Nitsch S, Krause B, Teipel S (2021) [LATE: not every dementia is Alzheimer\u2019s disease-Discussion of a new disease entity based on a case example: Current status of limbic-predominant age-related TDP-43 encephalopathy (LATE)]. Nervenarzt 92:18\u201326","journal-title":"Nervenarzt"},{"key":"1914_CR223","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/brain\/awaa219","volume":"143","author":"JL Robinson","year":"2020","unstructured":"Robinson JL, Porta S, Garrett FG, Zhang P, Xie SX, Suh E et al (2020) Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain 143:2844\u20132857","journal-title":"Brain"},{"key":"1914_CR224","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-021-01260-0","volume":"9","author":"S Agrawal","year":"2021","unstructured":"Agrawal S, Yu L, Nag S, Arfanakis K, Barnes LL, Bennett DA et al (2021) The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer\u2019s dementia in older persons. Acta Neuropathol Commun 9:156","journal-title":"Acta Neuropathol Commun"},{"key":"1914_CR225","doi-asserted-by":"publisher","first-page":"e2056","DOI":"10.1212\/WNL.0000000000010602","volume":"95","author":"S Nag","year":"2020","unstructured":"Nag S, Barnes LL, Yu L, Wilson RS, Bennett DA, Schneider JA (2020) Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology 95:e2056\u2013e2064","journal-title":"Neurology"},{"key":"1914_CR226","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/neup.12185","volume":"35","author":"K Oyanagi","year":"2015","unstructured":"Oyanagi K, Yamazaki M, Hashimoto T, Asakawa M, Wakabayashi K, Takahashi H (2015) Hippocampal sclerosis in the parkinsonism-dementia complex of Guam: quantitative examination of neurons, neurofibrillary tangles, and TDP-43 immunoreactivity in CA1. Neuropathology 35:224\u2013235","journal-title":"Neuropathology"},{"key":"1914_CR227","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.24388","volume":"77","author":"S Nag","year":"2015","unstructured":"Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA et al (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol 77:942\u2013952","journal-title":"Ann Neurol"},{"key":"1914_CR228","first-page":"395","volume":"145","author":"R Nicks","year":"2024","unstructured":"Nicks R, Clement NF, Alvarez VE, Tripodis Y, Baucom ZH, Huber BR et al (2024) sclerosis 145:395\u2013408","journal-title":"sclerosis"},{"key":"1914_CR229","doi-asserted-by":"publisher","first-page":"E1422","DOI":"10.1212\/WNL.0000000000200001","volume":"98","author":"KM Gauthreaux","year":"2022","unstructured":"Gauthreaux KM, Teylan MA, Katsumata Y, Mock C, Culhane JE, Chen YC et al (2022) Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis. Neurology 98:E1422\u2013E1433","journal-title":"Neurology"},{"key":"1914_CR230","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"H-S Yang","year":"2018","unstructured":"Yang H-S, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA et al (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol 17:773\u2013781","journal-title":"Lancet Neurol"},{"key":"1914_CR231","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.5858\/arpa.2016-0469-SA","volume":"141","author":"MD Cykowski","year":"2017","unstructured":"Cykowski MD, Powell SZ, Schulz PE, Takei H, Rivera AL, Jackson RE et al (2017) Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis. Arch Pathol Lab Med 141:1113\u20131126","journal-title":"Arch Pathol Lab Med"},{"key":"1914_CR232","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2019.01.013","volume":"125","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Gal Z, Wang W-X, Niedowicz DM, Artiushin SC, Wycoff S et al (2019) TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels. Neurobiol Dis 125:67\u201376","journal-title":"Neurobiol Dis"},{"key":"1914_CR233","unstructured":"Bajwa H, Azhar W (2024) Niemann-Pick Disease. Treasure Island (FL)"},{"key":"1914_CR234","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-016-0325-4","volume":"4","author":"A Dardis","year":"2016","unstructured":"Dardis A, Zampieri S, Canterini S, Newell KL, Stuani C, Murrell JR et al (2016) Altered localization and functionality of TAR DNA Binding Protein 43 (TDP-43) in niemann- pick disease type C. Acta Neuropathol Commun 4:52","journal-title":"Acta Neuropathol Commun"},{"key":"1914_CR235","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/nan.12738","volume":"47","author":"EA Liu","year":"2021","unstructured":"Liu EA, Mori E, Hamasaki F, Lieberman AP (2021) TDP-43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann-Pick C disease. Neuropathol Appl Neurobiol 47:1019\u20131032","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1914_CR236","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jnen\/63.4.323","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Suzuki K, Hulette CM, Murayama S (2004) Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 63:323\u2013328","journal-title":"J Neuropathol Exp Neurol"},{"key":"1914_CR237","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/neup.12047","volume":"34","author":"Y Chiba","year":"2014","unstructured":"Chiba Y, Komori H, Takei S, Hasegawa-Ishii S, Kawamura N, Adachi K et al (2014) Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: an autopsy case. Neuropathology 34:49\u201357","journal-title":"Neuropathology"},{"key":"1914_CR238","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bpa.12601","volume":"28","author":"A Sosunov","year":"2018","unstructured":"Sosunov A, Olabarria M, Goldman JE (2018) Alexander disease: an astrocytopathy that produces a leukodystrophy. Brain Pathol 28:388\u2013398","journal-title":"Brain Pathol"},{"key":"1914_CR239","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1523\/JNEUROSCI.0248-14.2014","volume":"34","author":"AK Walker","year":"2014","unstructured":"Walker AK, Daniels CML, Goldman JE, Trojanowski JQ, Lee VM-Y, Messing A (2014) Astrocytic TDP-43 pathology in Alexander disease. J Neurosci Off J Soc Neurosci 34:6448\u20136458","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1914_CR240","doi-asserted-by":"publisher","first-page":"e00109","DOI":"10.1042\/AN20130003","volume":"5","author":"PL Jany","year":"2013","unstructured":"Jany PL, Hagemann TL, Messing A (2013) GFAP expression as an indicator of disease severity in mouse models of Alexander disease. ASN Neuro 5:e00109","journal-title":"ASN Neuro"},{"key":"1914_CR241","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1523\/JNEUROSCI.0567-11.2011","volume":"31","author":"J Tao","year":"2011","unstructured":"Tao J, Wu H, Lin Q, Wei W, Lu X-H, Cantle JP et al (2011) Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J Neurosci Off J Soc Neurosci 31:8306\u20138319","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1914_CR242","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"PH Tu","year":"1998","unstructured":"Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S et al (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415\u2013422","journal-title":"Ann Neurol"},{"key":"1914_CR243","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/pn-2020-002797","volume":"23","author":"YY Goh","year":"2023","unstructured":"Goh YY, Saunders E, Pavey S, Rushton E, Quinn N, Houlden H et al (2023) Multiple system atrophy. Pract Neurol 23:208\u2013221","journal-title":"Pract Neurol"},{"key":"1914_CR244","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12485","volume":"44","author":"S Koga","year":"2018","unstructured":"Koga S, Lin W-L, Walton RL, Ross OA, Dickson DW (2018) TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and \u03b1-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol 44:707\u2013721","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1914_CR245","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2990.2010.01136.x","volume":"37","author":"F Geser","year":"2011","unstructured":"Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S et al (2011) TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol 37:358\u2013365","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1914_CR246","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/mdc3.12823","volume":"6","author":"L Nwabuobi","year":"2019","unstructured":"Nwabuobi L, Tomishon D, Shneider NA, Fahn S, Vonsattel JP, Cortes E (2019) Multiple System Atrophy With Predominant Striatonigral Degeneration and TAR DNA-Binding Protein of 43\u00a0kDa Pathology: An Unusual Variant of Multiple System Atrophy. Mov Disord Clin Pract 6:661\u2013666","journal-title":"Mov Disord Clin Pract"},{"key":"1914_CR247","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, \u00d6zdemir S, Fritz C, M\u00f6bius W, Kleineidam L, Mandelkow E et al (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med 30:1771\u20131783","journal-title":"Nat Med"},{"key":"1914_CR248","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","volume":"120","author":"O Yokota","year":"2010","unstructured":"Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T et al (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55\u201366","journal-title":"Acta Neuropathol"},{"key":"1914_CR249","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.26809","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA et al (2017) Distribution and characteristics of transactive response DNA binding protein 43\u00a0kDa pathology in progressive supranuclear palsy. Mov Disord 32:246\u2013255","journal-title":"Mov Disord"},{"key":"1914_CR250","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00702-023-02691-w","volume":"130","author":"KA Jellinger","year":"2023","unstructured":"Jellinger KA (2023) Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration. J Neural Transm 130:1509\u20131522","journal-title":"J Neural Transm"},{"key":"1914_CR251","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555\u2013564","journal-title":"J Neuropathol Exp Neurol"},{"key":"1914_CR252","doi-asserted-by":"crossref","unstructured":"Sainouchi M, Tada M, Ady Y, Norikazu F, Tanaka K, Idezuka J et al (2022) Brain TDP-43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss.;1\u201312","DOI":"10.1111\/nan.12786"},{"key":"1914_CR253","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","volume":"136","author":"S Koga","year":"2018","unstructured":"Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I et al (2018) Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol 136:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"1914_CR254","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","volume":"125","author":"N Kouri","year":"2013","unstructured":"Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE et al (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741\u2013752","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01914-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01914-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01914-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:04:32Z","timestamp":1735643072000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01914-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":254,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01914-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}